Medinova Diagnostic Services Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹26.84
- Today's High:
- ₹29
- Open Price:
- ₹28.5
- 52W Low:
- ₹17.2
- 52W High:
- ₹31.9
- Prev. Close:
- ₹28.25
- Volume:
- 8127
Company Statistics
- Market Cap.:
- ₹133.25 million
- Book Value:
- Revenue TTM:
- ₹70.78 million
- Operating Margin TTM:
- 2.98%
- Gross Profit TTM:
- ₹42.26 million
- Profit Margin:
- -3.01%
- Return on Assets TTM:
- 0%
- Return on Equity TTM:
- 0%
Company Profile
Medinova Diagnostic Services Limited had its IPO on under the ticker symbol 526301.
The company operates in the Other sector and Other industry. Medinova Diagnostic Services Limited has a staff strength of 71 employees.
Stock update
Shares of Medinova Diagnostic Services Limited opened at ₹28.5 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹26.84 - ₹29, and closed at ₹28.4.
This is a +0.53% increase from the previous day's closing price.
A total volume of 8,127 shares were traded at the close of the day’s session.
In the last one week, shares of Medinova Diagnostic Services Limited have increased by +10.94%.
Medinova Diagnostic Services Limited's Key Ratios
Medinova Diagnostic Services Limited has a market cap of ₹133.25 million, indicating a price to book ratio of 0 and a price to sales ratio of 1.9519.
In the last 12-months Medinova Diagnostic Services Limited’s revenue was ₹70.78 million with a gross profit of ₹42.26 million and an EBITDA of ₹10.78 million. The EBITDA ratio measures Medinova Diagnostic Services Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Medinova Diagnostic Services Limited’s operating margin was 2.98% while its return on assets stood at 0% with a return of equity of 0%.
In Q2, Medinova Diagnostic Services Limited’s quarterly earnings growth was a positive 0% while revenue growth was a negative 22.3%.
Medinova Diagnostic Services Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 14.8277
- PEG
Its diluted EPS in the last 12-months stands at ₹-0.211 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Medinova Diagnostic Services Limited’s profitability.
Medinova Diagnostic Services Limited stock is trading at a EV to sales ratio of 2.7006 and a EV to EBITDA ratio of 17.7924. Its price to sales ratio in the trailing 12-months stood at 1.9519.
Medinova Diagnostic Services Limited stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹44.79 million
- Total Liabilities
- ₹35.91 million
- Operating Cash Flow
- ₹-3396000.00
- Capital Expenditure
- ₹3.87 million
- Dividend Payout Ratio
- 0%
Medinova Diagnostic Services Limited ended 2024 with ₹44.79 million in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹44.79 million while shareholder equity stood at ₹-51357000.00.
Medinova Diagnostic Services Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹35.91 million in other current liabilities, 99568000.00 in common stock, ₹-150925000.00 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹7.80 million and cash and short-term investments were ₹7.83 million. The company’s total short-term debt was ₹0 while long-term debt stood at ₹57.50 million.
Medinova Diagnostic Services Limited’s total current assets stands at ₹16.91 million while long-term investments were ₹0 and short-term investments were ₹32000.00. Its net receivables were ₹7.03 million compared to accounts payable of ₹0 and inventory worth ₹1.22 million.
In 2024, Medinova Diagnostic Services Limited's operating cash flow was ₹-3396000.00 while its capital expenditure stood at ₹3.87 million.
Comparatively, Medinova Diagnostic Services Limited paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹28.4
- 52-Week High
- ₹31.9
- 52-Week Low
- ₹17.2
- Analyst Target Price
- ₹
Medinova Diagnostic Services Limited stock is currently trading at ₹28.4 per share. It touched a 52-week high of ₹31.9 and a 52-week low of ₹31.9. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹24.96 and 200-day moving average was ₹24.36 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 7202% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Medinova Diagnostic Services Limited
Similar Industry Stocks (Other)
Most Active
Top Gainers
Top Losers
About
Medinova Diagnostic Services Limited, together with its subsidiary, Medinova Millennium MRI Services LLP, provides medical diagnostic services in India. It offers blood test, MRI/CT scan, digital X-ray, ultra-sonography, bone densitometry, 2D echo color doppler, vascular study, cardiac stress lab, ECG, EEG, biochemistry, haematology, microbiology, and histopathology services; and home visit, lab samples, reports delivery, and ambulance services. The company also provides lipid, cardiac, hypertension, renal, hepatic, orthopedic, and rheumatoid profiles. In addition, it operates a training and research institution in Pune. The company serves company executives, government employees, industrial workers, etc., as well as people in rural and semi urban areas. It operates four centers located in Hyderabad, Kolkata, and Pune; and three franchise centers. The company was founded in 1985 and is based in Hyderabad, India. Medinova Diagnostic Services Limited is a subsidiary of Vijaya Diagnostic Centre Private Limited.